Literature DB >> 19293232

Compensation of loss of protein function in microsatellite-unstable colon cancer cells (HCT116): a gene-dependent effect on the cell surface glycan profile.

Georgios Patsos1, Sabine André, Nina Roeckel, Roland Gromes, Johannes Gebert, Jürgen Kopitz, Hans-Joachim Gabius.   

Abstract

Tumors that display a high level of microsatellite instability (MSI-H) accumulate somatic frameshift mutations in several genes. The compensation of this loss of function by transfection represents a suitable approach to tie respective gene deficiency to alterations in cellular characteristics. In view of the emerging significance of cell surface glycans as biochemical signals for presentation/activity of various receptors/integrins and for susceptibility to adhesion/growth-regulatory tissue lectins, we examined the glycophenotype in the MSI-H colon cancer cell line HCT116 for activin type 2 receptor (ACVR2), absent in melanoma 2 (AIM2), and transforming growth factor beta-type 2 receptor (TGFBR2) known to be associated with MSI colorectal carcinogenesis. A panel of probes specific for functional carbohydrate epitopes including human lectins was used to trace changes in cell surface levels, thereby initiating glycan analysis related to MSI. In particular, the presence of core substitutions and branching in N-glycans, the sialylation status of N- and O-glycans, and the presence of Le(a/x)-epitopes were profiled. Transient transfection affected the glycophenotype, depending on the nature of the gene and the probe. The TGFBR2 presence reduced binding of probes specific for a core substitution and increased branch length in N-glycosylation, even reaching a P-value of 0.0016. ACVR2/AIM2 influenced core 1 mucin-type O-glycosylation differentially, upregulation by ACVR2, and downregulation by AIM2. These alterations of cell surface glycosylation by gene products that are not directly associated with the machinery for glycan generation direct attention to pursue analysis of glycosylation in MSI tumor cells on the level of target glycoproteins and open the way for functional studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19293232     DOI: 10.1093/glycob/cwp040

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  16 in total

Review 1.  From glycophenotyping by (plant) lectin histochemistry to defining functionality of glycans by pairing with endogenous lectins.

Authors:  Herbert Kaltner; Gabriel García Caballero; Anna-Kristin Ludwig; Joachim C Manning; Hans-Joachim Gabius
Journal:  Histochem Cell Biol       Date:  2018-05-05       Impact factor: 4.304

Review 2.  Absent in melanoma 2 proteins in the development of cancer.

Authors:  Divaker Choubey
Journal:  Cell Mol Life Sci       Date:  2016-06-21       Impact factor: 9.261

3.  Galectin-1 sensitizes carcinoma cells to anoikis via the fibronectin receptor α5β1-integrin.

Authors:  H Sanchez-Ruderisch; K M Detjen; M Welzel; S André; C Fischer; H-J Gabius; S Rosewicz
Journal:  Cell Death Differ       Date:  2010-11-26       Impact factor: 15.828

4.  Ganglioside GM1/galectin-dependent growth regulation in human neuroblastoma cells: special properties of bivalent galectin-4 and significance of linker length for ligand selection.

Authors:  Jürgen Kopitz; Seda Ballikaya; Sabine André; Hans-Joachim Gabius
Journal:  Neurochem Res       Date:  2012-01-11       Impact factor: 3.996

Review 5.  Lipid glycosylation: a primer for histochemists and cell biologists.

Authors:  Jürgen Kopitz
Journal:  Histochem Cell Biol       Date:  2016-12-20       Impact factor: 4.304

6.  Galectins as tools for glycan mapping in histology: comparison of their binding profiles to the bovine zona pellucida by confocal laser scanning microscopy.

Authors:  Felix A Habermann; Sabine André; Herbert Kaltner; Dieter Kübler; Fred Sinowatz; Hans-Joachim Gabius
Journal:  Histochem Cell Biol       Date:  2011-05-17       Impact factor: 4.304

7.  Colonic carcinogenesis along different genetic routes: glycophenotyping of tumor cases separated by microsatellite instability/stability.

Authors:  Johannes Gebert; Matthias Kloor; Jennifer Lee; Michaela Lohr; Sabine André; Rudolf Wagner; Juergen Kopitz; Hans-Joachim Gabius
Journal:  Histochem Cell Biol       Date:  2012-05-08       Impact factor: 4.304

8.  De Novo proteome analysis of genetically modified tumor cells by a metabolic labeling/azide-alkyne cycloaddition approach.

Authors:  Seda Ballikaya; Jennifer Lee; Uwe Warnken; Martina Schnölzer; Johannes Gebert; Jürgen Kopitz
Journal:  Mol Cell Proteomics       Date:  2014-09-15       Impact factor: 5.911

9.  Transforming growth factor beta receptor 2 (TGFBR2) changes sialylation in the microsatellite unstable (MSI) Colorectal cancer cell line HCT116.

Authors:  Jennifer Lee; Seda Ballikaya; Kai Schönig; Claudia R Ball; Hanno Glimm; Juergen Kopitz; Johannes Gebert
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

Review 10.  Sweet and sour: the impact of differential glycosylation in cancer cells undergoing epithelial-mesenchymal transition.

Authors:  Leonardo Freire-de-Lima
Journal:  Front Oncol       Date:  2014-03-25       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.